As part of our continued commitment to fostering international dialogue on health policy and market access, ECHORA was honoured to host Professor Jing Wu, Director of the Pharmacoeconomics Section of the Chinese Pharmaceutical Association and Professor at Tianjin University, for a keynote lecture on 13 March 2025. In this online session, delivered as part of the ECHORA Annual … Continue reading ECHORA Lecture: Value assessment and economic evaluation of innovative drugs in China
ECHORA Lecture: The Impact of Climate Change on Dementia-related Hospitalisations and Mortality in China
As the global ecological landscape continues to shift, climate change has become an inescapable reality. According to the China Climate Change Blue Book (2024), the global warming trend shows no signs of slowing. In 2023, China’s annual average surface temperature was 0.84°C above the historical norm. Meanwhile, extreme weather events are growing both more frequent and … Continue reading ECHORA Lecture: The Impact of Climate Change on Dementia-related Hospitalisations and Mortality in China
ECHORA in UCL HEPL Symposium on Economic Evaluation in Trials and Real-World Research
On 20 February 2025, University College London hosted a focused symposium on economic evaluations alongside clinical trials and using real-world evidence. The event brought together researchers across disciplines to explore how economic data can shape more effective and equitable healthcare. Among the contributors were several early-career scholars affiliated with the Europe - China Health Outcomes and Research … Continue reading ECHORA in UCL HEPL Symposium on Economic Evaluation in Trials and Real-World Research
ECHORA Global 